YD Bio Stock (NASDAQ:YDES)
Previous Close
$18.50
52W Range
$5.30 - $25.00
50D Avg
$17.01
200D Avg
$17.01
Market Cap
$1.33B
Avg Vol (3M)
$126.43K
Beta
0.16
Div Yield
-
YDES Company Profile
Breeze Holdings Acquisition Corp. operates as a clinical-stage biopharmaceutical company focuses on cancer prevention medical diagnostics and the development of exosome-based therapeutics with the potential to transform the treatment of a diseases with unmet medical need. The company is based in Taipei, Taiwan.
Industry
Biotechnology
Sector
Healthcare
Exchange
NASDAQ
ADR
-
Country
KY
Employees
-
IPO Date
Aug 29, 2025
Website
-